Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | RCUS |
---|---|---|
09:32 ET | 2364 | 15.585 |
09:38 ET | 1916 | 15.595 |
09:41 ET | 1304 | 15.6185 |
09:43 ET | 235 | 15.61 |
09:45 ET | 1207 | 15.625 |
09:48 ET | 100 | 15.67 |
09:50 ET | 300 | 15.67 |
09:52 ET | 505 | 15.65 |
09:54 ET | 300 | 15.63 |
09:56 ET | 1729 | 15.67 |
09:57 ET | 305 | 15.64 |
09:59 ET | 200 | 15.63 |
10:01 ET | 1108 | 15.615 |
10:03 ET | 300 | 15.68 |
10:08 ET | 100 | 15.62 |
10:10 ET | 300 | 15.64 |
10:12 ET | 300 | 15.66 |
10:14 ET | 300 | 15.635 |
10:15 ET | 300 | 15.615 |
10:17 ET | 200 | 15.6 |
10:19 ET | 100 | 15.63 |
10:21 ET | 400 | 15.63 |
10:24 ET | 803 | 15.64 |
10:26 ET | 1449 | 15.67 |
10:28 ET | 100 | 15.68 |
10:30 ET | 1927 | 15.67 |
10:32 ET | 676 | 15.665 |
10:33 ET | 100 | 15.61 |
10:35 ET | 448 | 15.63 |
10:37 ET | 870 | 15.63 |
10:39 ET | 108 | 15.64 |
10:42 ET | 850 | 15.65 |
10:44 ET | 407 | 15.7 |
10:46 ET | 357 | 15.72 |
10:48 ET | 744 | 15.72 |
10:50 ET | 300 | 15.72 |
10:51 ET | 441 | 15.69 |
10:53 ET | 701 | 15.67 |
10:55 ET | 300 | 15.66 |
10:57 ET | 600 | 15.63 |
11:00 ET | 100 | 15.66 |
11:02 ET | 310 | 15.68 |
11:06 ET | 100 | 15.67 |
11:08 ET | 300 | 15.65 |
11:09 ET | 1004 | 15.615 |
11:11 ET | 5491 | 15.57 |
11:18 ET | 1991 | 15.6 |
11:20 ET | 152 | 15.59 |
11:22 ET | 1552 | 15.59 |
11:24 ET | 100 | 15.58 |
11:26 ET | 200 | 15.59 |
11:27 ET | 400 | 15.54 |
11:29 ET | 200 | 15.56 |
11:31 ET | 200 | 15.57 |
11:33 ET | 1209 | 15.585 |
11:36 ET | 603 | 15.6 |
11:38 ET | 1877 | 15.56 |
11:40 ET | 942 | 15.52 |
11:42 ET | 400 | 15.51 |
11:44 ET | 523 | 15.53 |
11:47 ET | 400 | 15.53 |
11:49 ET | 225 | 15.51 |
11:51 ET | 100 | 15.52 |
11:58 ET | 442 | 15.56 |
12:02 ET | 100 | 15.54 |
12:03 ET | 399 | 15.56 |
12:05 ET | 950 | 15.55 |
12:07 ET | 300 | 15.53 |
12:09 ET | 200 | 15.52 |
12:12 ET | 300 | 15.5 |
12:16 ET | 1658 | 15.45 |
12:20 ET | 715 | 15.45 |
12:25 ET | 425 | 15.43 |
12:27 ET | 400 | 15.43 |
12:32 ET | 758 | 15.42 |
12:34 ET | 200 | 15.43 |
12:36 ET | 1897 | 15.42 |
12:39 ET | 6067 | 15.42 |
12:41 ET | 536 | 15.39 |
12:43 ET | 303 | 15.38 |
12:45 ET | 500 | 15.38 |
12:50 ET | 200 | 15.38 |
12:52 ET | 200 | 15.365 |
12:57 ET | 100 | 15.39 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Arcus Biosciences Inc | 1.4B | -5.0x | --- |
Ardelyx Inc | 1.5B | -24.9x | --- |
Gyre Therapeutics Inc | 1.2B | -14.7x | --- |
Nurix Therapeutics Inc | 1.5B | -8.0x | --- |
Xencor Inc | 1.4B | -7.1x | --- |
Immatics NV | 1.2B | -12.6x | --- |
Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company developing differentiated molecules and combination therapies for people with cancer. The Company involves in a portfolio of investigational products, which are in clinical development with its advanced molecule, an anti-TIGIT antibody targeting lung and gastrointestinal cancers. The Company has approximately seven clinical programs that are focused on targets, including TIGIT, PD-1, adenosine A2a and A2b receptors, CD73, CD39, HIF-2a, and AXL. The Company is engaged in co-developing four investigational products, including zimberelimab (Arcuss anti-PD-1 molecule), domvanalimab (Arcuss anti-TIGIT antibody), etrumadenant (Arcuss adenosine receptor antagonist) and quemliclustat (Arcuss CD73 inhibitor). It is engaged in pursuing a Phase II and Phase III development program for domvanalimab in combination with its anti-PD-1 antibody, zimberelimab, in multiple settings, including lung and gastrointestinal cancer.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.4B |
---|---|
Revenue (TTM) | $247.0M |
Shares Outstanding | 91.4M |
Arcus Biosciences Inc does not pay a dividend. | |
Beta | 0.88 |
EPS | $-3.10 |
Book Value | $6.12 |
P/E Ratio | -5.0x |
Price/Sales (TTM) | 5.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -118.62% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.